Aleafia Health Inc.
ALEAF · OTC
3/31/2023 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Revenue | $42,847 | $44,542 | $16,351 | $3,330 |
| % Growth | -3.8% | 172.4% | 391% | – |
| Cost of Goods Sold | $36,848 | $50,152 | -$4,431 | $542 |
| Gross Profit | $5,999 | -$5,610 | $20,782 | $2,788 |
| % Margin | 14% | -12.6% | 127.1% | 83.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $17,702 | $31,939 | $38,853 | $20,006 |
| SG&A Expenses | $20,165 | $31,939 | $38,853 | $20,940 |
| Sales & Mktg Exp. | $2,463 | $0 | $0 | $933 |
| Other Operating Expenses | $3,373 | $8,058 | $5,912 | $1,659 |
| Operating Expenses | $23,538 | $39,997 | $44,765 | $22,599 |
| Operating Income | -$17,539 | $153,753 | -$23,983 | -$19,810 |
| % Margin | -40.9% | 345.2% | -146.7% | -594.9% |
| Other Income/Exp. Net | -$17,068 | -$403,531 | -$12,665 | $270 |
| Pre-Tax Income | -$34,607 | -$249,778 | -$36,648 | -$19,540 |
| Tax Expense | $7,711 | -$2,540 | $2,959 | -$1,008 |
| Net Income | -$42,318 | -$247,238 | -$39,607 | -$18,533 |
| % Margin | -98.8% | -555.1% | -242.2% | -556.5% |
| EPS | -0.11 | -0.85 | -0.18 | -0.16 |
| % Growth | 87.1% | -372.2% | -12.5% | – |
| EPS Diluted | -0.11 | -0.85 | -0.18 | -0.16 |
| Weighted Avg Shares Out | 386,359 | 291,590 | 215,619 | 117,162 |
| Weighted Avg Shares Out Dil | 386,359 | 291,590 | 215,619 | 117,162 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $417 | $170 |
| Interest Expense | $9,357 | $403,531 | $6,376 | $0 |
| Depreciation & Amortization | $6,565 | $10,164 | $6,631 | $1,559 |
| EBITDA | -$10,974 | $163,917 | -$17,352 | -$18,251 |
| % Margin | -25.6% | 368% | -106.1% | -548.1% |